RespirTech
Private Company
Total funding raised: $20M
Overview
RespirTech operates as a specialized distributor and service provider in the respiratory and digital health sectors, focusing on chronic conditions like bronchiectasis, cystic fibrosis, and neuromuscular diseases. Its core business involves providing Philips-manufactured high-frequency chest wall oscillation (HFCWO) and mechanical insufflation-exsufflation devices, complemented by a high-touch service model featuring licensed respiratory therapists and nurses. Founded in 2004, the company has established a strong clinical support and reimbursement navigation framework, positioning itself as a key facilitator between large medical device manufacturers and patients requiring chronic respiratory therapy.
Technology Platform
Distribution and integrated service support platform for Philips airway clearance devices (High Frequency Chest Wall Oscillation and Mechanical Insufflation-Exsufflation), including clinical specialist support, patient training, and reimbursement navigation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
RespirTech competes in the airway clearance device market, which includes other manufacturers of HFCWO vests (e.g., Hillrom, International Biophysics) and mechanical cough assist devices. Its primary differentiation is not the hardware but its wrapped-around service model of clinical specialist support and reimbursement expertise, which is less common among pure DME distributors.